Marché indien des analyseurs de gaz sanguins – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse et perspectives du marché indien des analyseurs de gaz sanguins

L'adaptation des technologies avancées pour l'analyse du sang dans l'industrie a été stimulée par la nécessité d'améliorer la qualité des produits et de réduire les coûts de fabrication en même temps, ou plutôt, de garantir la compétitivité. Par conséquent, la demande croissante d'analyseurs de gaz sanguins dans le secteur de la santé devrait stimuler la croissance du marché au cours de la période projetée.

L’incidence croissante des troubles chroniques tels que les maladies cardiovasculaires et neurologiques accélère la croissance du marché.

Le marché indien des analyseurs de gaz sanguins devrait atteindre 88,51 millions USD d'ici 2030, contre 51,08 millions USD en 2022, avec un TCAC de 7,1 % au cours de la période de prévision de 2023 à 2030.

Définition du marché

Le terme « analyse des gaz du sang » (BGA) est utilisé pour les tests de laboratoire qui se connectent à l'équilibre de base corrosif et à l'état d'oxygène d'un patient. L'état d'oxygène est évalué à l'aide de la pression fractionnelle d'O2 (pO2) et de la saturation en oxygène de l'hémoglobine (sO2).

La pression partielle d'O2 (pO2) est mesurée par ampérométrie, tandis que celle de SO2 est mesurée par co-oxymétrie. Les analyseurs de gaz du sang qui ne disposent pas d'un co-oxymètre intégré rapportent le SO2 évalué à partir de PO et de différentes limites.

Les analyseurs actuels mesurent non seulement les paramètres des gaz du sang, mais également les électrolytes (PH, sodium, potassium, chlorure, calcium ionisé, magnésium ionisé) et les métabolites (glucose, lactate, bilirubine et créatinine). Les services d'urgence et de soins intensifs utilisent le BGA comme élément essentiel de l'évaluation de l'état clinique d'un patient.

Dynamique du marché indien des analyseurs de gaz sanguins

Conducteurs

• Rising prevalence of chronic disorders

The change in lifestyle habits, such as smoking tobacco, drinking liquor, having a stationary way of life, and numerous others, has raised the instances of patients experiencing constant ailment. The rising prevalence of chronic disorders is expected to boost market growth and positively influence the blood gas analyzer market.

• Increased number of patients treated in emergency care and intensive care units

The increased number of patients being treated in NICUs, emergency departments, and ICUs is rising with the increase in the number of chronic disorders, which is leading more patients into NICUs, emergency departments, and ICUs. The increased number of patients treated in emergency care and intensive care units will act as one of the major drivers in the growth of the India blood gas analyzer market.

• Increase in the number of product launches

Growing research activities to miniaturize the blood gas analyzer presents a great opportunity and a large number of product approval by market key players. The products perform multiple tests and provide coverage of wide results that will help in the rise of the blood analyzer market. The product portfolio for the companies working in this market is vast, and due to this, the revenue of the companies has increased continuously from the past recent revenue years. An increased number of product approval will act as a driver to boost the growth of the India blood gas analyzer market in the forecast period.

Opportunities

• Rising technological advancement in blood gas analyzer

Technological advancement plays an important role in almost all processes of the healthcare industry, such as the possibility of medication errors, which exist due to an increase in disease burden, patient registration for data management, and laboratory testing for self-care equipment. The reach of these technological innovations can be seen in healthcare with the development of technologies. The commercialization of advanced technology-based blood gas analyzers has increased its demand among consumers due to the increasing prevalence of chronic diseases, raising the need for the India blood gas analyzer market.

• Increasing initiatives by governmental bodies for diagnostic tools

Many governmental agencies and key market players in the blood gas analyzer market are involved in spreading the use and importance of devices among society and across the state. These initiatives by the market players and government are helping the users to reach out to take advantage of the policies made for low-income and developing states that make them aware of preventable diseases if diagnosed earlier. The growth of blood gas analyzer in hospitals and emergency rooms are strongly encouraged due to the increased prevalence of chronic diseases in the nation and rising initiatives by government bodies. Various government bodies are taking initiatives to extend healthcare facilities to remote regions, such as Ayushman Bharat Yojana and National Rural Health Mission among others. Increasing initiatives by the government bodies are acting as an opportunity for the growth of the India blood gas analyzer market.

Restraints/Challenges

• Lack of skilled professionals

The lack of capable laboratory professionals is not a new story in diagnosis and healthcare. As with the increase in the burden of chronic diseases, the increase in the aged population and the development of healthcare insurance have increased the demand for healthcare laboratory professionals. Another reason is the lack of training sessions for the professionals. Factors such as the retention rate and workload lack of certification are reasons for the lack of trained laboratory manpower, lack of education, and relevant degrees. These factors are hampering the growth of the India blood gas analyzer market.

• Lack of reimbursement policies for blood gas analyzer

Reimbursement for blood gas analyzer tests and services has been under downward pressure for several years. The blood gas analyzer also faces major roadblocks in its growth due to the lack of reimbursement for these services.

The reimbursement of a device can significantly affect the ability of a provider to access a particular technology, as well as the willingness of a manufacturer to deliver it. If coverage is uncertain, the manufacturer has difficulty predicting whether an investment in new technology will yield enough returns. This lack of predictability is an apparent barrier to obtaining funding for the company. It further compromises innovation and restricts patient access to advanced technology and solutions.

Thus, inadequate reimbursement coverage may act as a restraint to the growth of the market in the forecast period.

• High cost associated with parts of analyzers

The rise in the cost of the blood gas analyzers components is due to robust research and effectiveness. However, the price of the material used and the developments incurred in the therapeutics and services would increase the number of manufacturing units and more workforce and human resources required to diagnose and screen pathogen viability. The rise in the cost of blood gas analyzers is due to technological development and increased demand for non-invasive in hospitals, clinics, nursing facilities, and ambulatory surgical centers. Therefore, the present high cost is expected to show a descending trend in the future.

Post-COVID-19 Impact on India Blood Gas Analyzer Market

COVID-19 has positively affected the India blood gas analyzers market. Lockdowns and isolation during pandemics complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration will further affect the market.

Recent Development

• In September 2021, Sensacore announced the launch of ST-200 CC Blood Gas Analyzer-Ultra Smart is the highly advanced blood gas model of Sensacore. It is a completely automated, microprocessor-controlled electrolyte system that uses direct current measurement with ION selective electrode (ISE), Impedance (Hct), and Amperometry (pO2) technology to make arterial blood gas analysis and electrolyte measurements
• In September 2020, Agappe diagnostics Ltd. launched a new hematology analyzer- Mispa Count X. Mispa Count X with Smart Impedance Technology is an advanced 3-part differential cell counter which offers quality CBC testing to deliver safe patient care

The India Blood Gas Analyzer Market Scope

India blood gas analyzer market is categorized into five notable segments such as product type, modality, medical condition, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

BY PRODUCT TYPE

• Instruments
• Consumables

On the basis of product type, the India blood gas analyzer market is segmented into instruments and consumables.

 BY MODALITY

• Benchtop
• Portable
• Handheld

On the basis of modality, the India blood gas analyzers market is segmented into handheld, benchtop, and portable.

 BY MEDICAL CONDITION

• Kidney dysfunction
• Cardiovascular disorder
• Diabetes
• Hemorrhage
• Others

On the basis of medical condition, the India blood gas analyzers market is segmented into kidney dysfunction, cardiovascular disorder, diabetes, hemorrhage, and others.

BY DISTRIBUTION CHANNEL

• Direct tender
• Retail sale

On the basis of distribution channel, the India blood gas analyzers market is segmented into direct tender and retail sale distributors.

BY END USERS

• Hospital
• Clinical laboratories
• Research/Academic institute
• Home setting
• Others

Sur la base des utilisateurs finaux, le marché indien des analyseurs de gaz sanguins est segmenté en hôpitaux, laboratoires cliniques, instituts de recherche/universitaires, environnement domestique et autres.

Analyse/perspectives régionales du marché indien des analyseurs de gaz sanguins   

Le marché indien des analyseurs de gaz sanguins est analysé et le type de produit, la modalité, l’état médical, l’utilisateur final et le canal de distribution fournissent des informations sur la taille et les tendances du marché.

La section par pays du rapport fournit également des facteurs individuels ayant un impact sur le marché et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données, tels que les ventes de produits neufs et de remplacement, la démographie des pays, l'épidémiologie des maladies et les tarifs d'importation et d'exportation, sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques d'Asie-Pacifique et les défis rencontrés en raison de la forte concurrence des marques locales et nationales, ainsi que l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché des analyseurs de gaz sanguins

Le paysage concurrentiel du marché indien des analyseurs de gaz sanguins fournit des détails sur les concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence en Inde, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que les entreprises se concentrant sur le marché indien des analyseurs de gaz sanguins.

Certaines des principales entreprises présentes sur le marché sont Abbott, Techno MedicaCo., Ltd., Nova Biomedical, WERFEN, Sensacore, OPTI Medical Systems, HDC India, AFFORD MEDICAL TECHNOLOGIES PVT. LTD., Radiometer India (une filiale de Danaher), Siemens Healthcare Private Limited (une filiale de Siemens), F. Hoffmann-La Roche Ltd., i-SENS, Inc., EDAN Instruments, Inc., ESCHWEILER GmbH & CO.KG, essential medical, Medica Corporation et Wondfo, entre autres.

SKU-69550